ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct Growth is a Equity Mutual Fund Scheme launched by ICICI Prudential Mutual Fund. This scheme was introduced to investors on 15 Jun 2018. Ihab Dalwai, Priyanka Khandelwal is the Current Fund Manager of ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct Growth.The fund currently has an Asset Under Management(AUM) of ₹1,287 Cr and the Latest NAV as of 17 Jan 2020 is ₹11.05.
The ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct Growth is rated High risk. Minimum SIP Investment is 100. Minimum Lumpsum Investment is 5000. Exit load of 1% if redeemed within 15 days..
Investment Objective
To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
Tax Implications
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.
Scheme Information Document(SID)
₹5000
Min for First Investment
₹1000
Min for Second Investment
Exit load of 1% if redeemed within 15 days.
Exit Load